Demographics | Value |
---|---|
Age | 68 (47–78) |
Gender (male/female) | 37 (75.5)/12 (24.5) |
Tumor location (U/M/L) | 3 (6.1)/21 (42.9)/25 (51.0) |
Initial depth of tumor invasion (T1 or T2/T3/T4) | 5 (10.2)/44 (89.8) |
Initial nodal status (positive/negative) | 18 (36.7)/31 (63.3) |
Initial TNM stage (I/II/III/IV) | 1 (2.0)/15 (30.6)/29 (59.2)/4 (8.2) |
Treatment (CRT/CT) | 10 (20.4)/39 (79.6) |
CS/SS | 39 (79.6)/10 (20.4) |
Pathological depth of tumor invasion (T0–T2/T3/T4) | 9 (18.4)/6 (12.2)/ 31 (63.3)/3 (6.1) |
Pathological nodal status (positive/negative) | 29 (59.2)/ 20 (40.8) |
Resection margin (R0/R1/R2) | 42 (85.7)/3 (6.1)/4 (8.2) |
Operation time (min) | 408 (250–732) |
Bleeding (mL) | 336 (40–2390) |
Postoperative hospital stay (days) | 23 (11–74) |
Major postoperative complications (CDII<) | |
 Pneumonia | 9 (18.4) |
 Anastomotic leak | 2 (4.0) |
 Recurrent laryngeal nerve palsy | 9 (18.4) |
 Surgery-related mortality | 0 (0.0) |